Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Medipoint Blood Lancets

K-Number: K223480 · 2023-01-13

Decision Date2023-01-13
Product CodeQRK
Advisory CommitteeSU
DecisionSubstantially Equivalent

Device Summary

Medipoint Blood Lancets is a medical device manufactured by Medipoint Holdings, LLC. It received FDA 510(k) clearance on 2023-01-13 under approval number K223480. The device is classified under product code QRK. It was reviewed by the SU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Medipoint Blood Lancets?

Medipoint Blood Lancets is a medical device that received FDA 510(k) clearance on 2023-01-13. It is manufactured by Medipoint Holdings, LLC. The 510(k) number is K223480.

When was Medipoint Blood Lancets approved by the FDA?

Medipoint Blood Lancets received FDA 510(k) clearance on 2023-01-13, under approval number K223480.

What company makes Medipoint Blood Lancets?

Medipoint Blood Lancets is manufactured by Medipoint Holdings, LLC.

What is the FDA product code for Medipoint Blood Lancets?

The FDA product code for Medipoint Blood Lancets is QRK.

Related Devices (Code: QRK)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.